HOB Biotech Group Corp Ltd (688656) — Cash Flow Reinvestment Rate
HOB Biotech Group Corp Ltd (688656) has a Cash Flow Reinvestment Rate of 0.33x as of September 2025, reinvesting CN¥11.30 Million (capex CN¥11.30 Million ) from operating cash flow of CN¥34.39 Million. Explore HOB Biotech Group Corp Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HOB Biotech Group Corp Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for HOB Biotech Group Corp Ltd across 9 annual periods. Also explore balance sheet size of HOB Biotech Group Corp Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for HOB Biotech Group Corp Ltd (2016–2024)
Year-by-year capital reinvestment analysis for HOB Biotech Group Corp Ltd. For live market cap and broader valuation context, see HOB Biotech Group Corp Ltd (688656) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.55x | CN¥156.43 Million | CN¥101.22 Million | CN¥155.37 Million | ▼ -27.1% |
| 2023 | 2.12x | CN¥217.58 Million | CN¥102.69 Million | CN¥178.03 Million | ▼ -78.1% |
| 2022 | 9.67x | CN¥564.07 Million | CN¥58.31 Million | CN¥220.21 Million | ▲ +214.6% |
| 2021 | 3.08x | CN¥322.28 Million | CN¥104.79 Million | CN¥167.89 Million | ▲ +94.5% |
| 2020 | 1.58x | CN¥92.04 Million | CN¥58.22 Million | CN¥57.01 Million | ▲ +58.1% |
| 2019 | 1.00x | CN¥68.55 Million | CN¥68.57 Million | CN¥34.80 Million | ▲ +74.4% |
| 2018 | 0.57x | CN¥26.66 Million | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥20.82 Million | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥17.15 Million | CN¥6.42 Million | CN¥17.15 Million | — |